THC Therapeutics, Inc. announced earnings results for the full year ended July 31, 2020. For the full year, the company announced operating loss was USD 1.318 million compared to USD 26.689 million a year ago. Net loss was USD 1.925 million compared to USD 23.307 million a year ago. Basic loss per share from continuing operations was USD 0.12 compared to USD 1.74 a year ago.